
University of California,
San Diego (UCSD)
Rebecca and John Moores UCSD
Cancer Center
La Jolla, CA
Bart's Cancer Centre of
Excellence
Barts Hospital
West Smithfield, London
The Burnham Institute
La Jolla, CA
Dana Farber Cancer Institute
Harvard Medical School
Boston, MA
Long Island Jewish Medical
Center
Division of Hematology/Oncology
New Hyde Park, NY
Mayo Clinic
Rochester, MN
M.D. Anderson Cancer Center
Houston, TX
Ohio State University
Cancer Center
Columbus, Ohio

Ohio State University Cancer Center
Columbus, Ohio
1-800-293-5066
http://www.jamesline.com
Dr. John Byrd is the Director of the Hematologic Malignancies Program at Ohio State University. His research interests focus on experimental therapeutics in hematologic cancers. Dr. Byrd currently heads several novel studies of promising new agents in the treatment of chronic lymphocytic leukemia. He has earned numerous awards, including the 2000 Col. William Crosby Superiority in Research Award.
Administrative Title:
D. Warren Brown Professor of Leukemia Research
Interim Co-Director, Division of Hematology and Oncology,
Department of Internal Medicine
Associate Director for Translational Research
The Comprehensive Cancer Center,
Arthur G. James Cancer Hospital
Faculty Title: Professor of Medicine and Medicinal Chemistry
Specialty Interests: Hematologic malignancies; Waldenstrom's Macroglobulinemia
Research Interests: Experimental therapeutics
Office:
320 West 10th Avenue
B302 Starling-Loving Hall
Columbus, OH 43210
Phone: (614) 293-9869
Fax: (614) 293-7526
ApptPhone: (614) 293-3196